Benzopyrazines and bis-Benzopyrazines
Combinatorial Chemistry & High Throughput Screening, 2015, Vol. 18, No. 1 55
2.2.5. 2,3-Diphenylbenzopyrazine (5, Entry 5, Table 2)
2.2.10. 6-Chloro-2-(3,4-difluorophenyl)Benzopyrazine (10,
Entry 10, Table 2)
Colorless crystals (88%); m.p. 119 °C; IR (KBr) 1665,
1560, 1489, 1240, 1184, 1077, 1012, 877, 807, 758, 698 cm-
1; 1H NMR (600 MHz, CDCl3) δ 7.36-7.40 (m, 6H), 7.55 (m,
4H), 7.79 (dd, J = 4.86, 3.00 Hz, 2H), 8.21 (dd, J = 4.86,
2.88 Hz, 2H); 13C NMR (150 MHz, CDCl3) 128.30, 128.83,
129.24, 129.89, 129.98, 139.13, 141.27, 153.49. Anal. Calcd
for C20H14N2: C, 85.08; H, 5.00; N, 9.92. Found: C, 84.97;
H, 4.92; N, 9.87.
Dark brown amorphous solid (95%); m.p. 172 °C; IR
(KBr) 1610, 1521, 1438, 1326, 1279, 1170, 1123, 1075, 885,
562 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.70 (dd, J = 13.70,
10.38 Hz, 1H), 7.89 (dd, J = 5.61, 2.34 Hz, 1H), 8.15 (d, J =
8.88 Hz, 1H), 8.39-8.43 (m, 1H), 9.64 (s, 1H); 13C NMR
(150 MHz, CDCl3) 116.62, 116.74, 118.33, 118.45, 124.89,
127.86, 130.71, 130.80, 133.25, 135.12, 139.80, 141.55,
143.99, 149.71; 19F NMR (564 MHz, CDCl3) -135.80 (d, J =
22.58 Hz, 1F), and -134.27 (d, J = 22.58 Hz, 1F). Anal.
Calcd for C14H7ClF2N2: C, 60.78; H, 2.55; N, 10.13. Found:
C, 60.71; H, 2.47; N, 10.05.
2.2.6. 6-Methoxy-2-Phenylbenzopyrazine (6, Entry 6, Table 2)
White crystalline solid (91%); m.p. 75-77 °C; IR (KBr)
1616, 1541, 1508, 1489, 1456, 1374, 1314, 1212, 1117,
1
1019, 827, 754, 687 cm-1; H NMR (600 MHz, CDCl3) δ
2.2.11. 6-Chloro-2-(3,4,5-Trimethoxyphenyl)Benzopyrazine
(11, Entry 11, Table 2)
3.90 (s, 3H), 7.30 (dd, J = 8.95, 2.76 Hz, 1H), 7.35 (d, J =
2.70 Hz, 1H), 7.43-7.49 (m, 3H), 7.90 (d, J = 9.06 Hz, 1H),
8.07 (s, 1H), 8.08 (m, 1H), 9.08 (s, 1H); 13C NMR (150
MHz, CDCl3) 55.84, 106.91, 122.89, 127.52, 129.10, 129.12,
130.05, 137.02, 137.80, 140.76, 143.98, 151.95, 161.08.
Anal. Calcd for C15H12N2O: C, 76.25; H, 5.12; N, 11.86.
Found: C, 76.14; H, 5.01; N, 11.78.
Deep brown amorphous solid (92%); m.p. 130-132 °C;
IR (KBr) 2940, 2834, 1590, 1456 1419, 1343, 1234, 1172,
1
1131, 1066, 994, 856 cm-1; H NMR (600 MHz, CDCl3) δ
3.96 (s, 3H), 4.03 (s, 6H), 7.43 (s, 2H), 7.68 (dd, J = 8.88,
2.10 Hz, 1H), 8.04-8.11 (m, 1H), 8.16 (d, J = 1.86 Hz, 1H),
9.28 (s, 1H); 13C NMR (150 MHz, CDCl3) 56.41, 61.03,
104.87, 104.95, 128.36, 130.34, 130.40, 131.35, 131.67,
140.00, 143.19, 143.94, 153.89, 153.90. Anal. Calcd for
C17H15ClN2O3: C, 61.73; H, 4.57; N, 8.47. Found: C, 61.64;
H, 4.49; N, 8.37.
2.2.7. 2-(3,4-Difluorophenyl)-6-Methoxybenzopyrazine (7,
Entry 7, Table 2)
Reddish amorphous solid (92%); m.p. 184 °C; IR (KBr)
1
1508, 1428, 1330, 1219, 1114, 1025, 830 cm-1; H NMR
(600 MHz, CDCl3) δ 3.98 (s, 3H), 7.51 (m, 2H), 7.67 (dd, J
= 13.74, 10.20 Hz, 1H), 8.02 (d, J = 9.84 Hz, 1H), 8.22 (br.
s, 1H) 8.39 (t, J = 9.78 Hz, 1H), 9.44 (s, 1H); 13C NMR (150
MHz, CDCl3) 55.93, 106.94, 116.27, 116.40, 118.21, 118.32,
123.09, 124.45, 129.90, 133.84, 137.33, 140.60, 142.94,
148.73, 160.79; 19F NMR (564 MHz, CDCl3) -136.24 (d, J =
20.47 Hz, 1F), and -135.34 (d, J = 20.94 Hz, 1F). Anal.
Calcd for C15H10F2N2O: C, 66.17; H, 3.70; N, 10.29. Found:
C, 66.12; H, 3.66; N, 10.24.
2.2.12. 6-Chloro-3-Methyl-2-Phenylbenzopyrazine (12,
Entry 12, Table 2)
Dark reddish-brown amorphous solid (96%); m.p. 119
°C; IR (KBr) 1604, 1552, 1477, 1372, 1332, 1173, 1126,
1063, 1001, 870, 765, 703 cm-1; 1H NMR (600 MHz, CDCl3)
δ 2.79 (s, 3H), 7.53-7.57 (m, 3H), 7.66-7.71 (m, 3H), 8.00-
8.07 (m, 1H), 8.12 (s, 1H); 13C NMR (150 MHz, CDCl3)
24.42, 128.61, 128.90, 128.92, 129.19, 129.25, 129.62,
130.25, 130.46, 130.69, 134.89, 141.32, 155.74. Anal. Calcd
for C15H11ClN2: C, 70.73; H, 4.35; N, 11.00. Found: C,
70.64; H, 4.41; N, 11.01.
2.2.8.
6-Methoxy-2-(3,4,5-Trimethoxyphenyl)Benzopyr-
azine (8, Entry 8, Table 2)
Yellowish brown crystalline solid (94%); m.p. 120-121
°C; IR (KBr) 2944, 2836, 1617, 1502, 1460, 1425, 1344,
2.2.13. 6-Nitro-2-Phenylbenzopyrazine (13, Entry 13, Table
2)
1
1215, 1129, 1000, 854 cm-1; H NMR (600 MHz, CDCl3) δ
3.86 (s, 3H), 3.92 (s, 3H), 3.94 (s, 6H), 7.32 (m, 1H), 7.33 (s,
2H), 7.36 (d, J = 2.70 Hz, 1H), 7.91 (d, J = 9.12 Hz, 1H),
9.04 (s, 1H); 13C NMR (150 MHz, CDCl3) 55.82, 56.39,
61.02, 104.84, 106.83, 122.79, 130.04, 132.49, 137.71,
140.13, 140.54, 143.86, 151.54, 153.83, 161.13. Anal. Calcd
for C18H18N2O4: C, 66.25; H, 5.56; N, 8.58. Found: C, 66.21;
H, 5.53; N, 8.57.
Pale yellow crystalline solid (97%); m.p. 210-211 °C; IR
(KBr) 1616, 1556, 1522, 1348, 1316, 1077, 851, 832, 791,
1
764, 691 cm-1; H NMR (600 MHz, CDCl3) δ 7.52-7.55 (m,
3H), 8.16-8.21 (m, 3H), 8.47 (dd, J = 9.12, 2.52 Hz, 1H),
8.95 (d, J = 2.46 Hz, 1H), 9.42 (s, 1H); 13C NMR (150 MHz,
CDCl3) 123.79, 125.67, 127.95, 129.43, 131.19, 131.41,
135.64, 140.36, 144.93, 145.50, 147.47, 154.33. Anal. Calcd
for C14H9N3O2: C, 66.93; H, 3.61; N, 16.73. Found: C,
66.78; H, 3.49; N, 16.66.
2.2.9. 6-Chloro-2-Phenylbenzopyrazine (9, Entry 9, Table 2)
Light brown crystalline solid (93%); m.p. 146-147 °C; IR
(KBr) 1699, 1540, 1481, 1449, 1315, 1223, 1132, 1073, 958,
829, 756, 711, 687 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.47-
7.51 (m, 3H), 7.61 (dd, J = 8.85, 2.22 Hz, 1H), 7.98 (d, J =
8.82 Hz, 1H), 8.01-8.04 (m, 1H), 8.08 (d, J = 2.16 Hz, 1H),
8.10-8.12 (m, 1H), 9.24 (s, 1H); 13C NMR (150 MHz,
CDCl3) 127.54, 127.63, 129.24, 130.37, 130.46, 130.54,
130.57, 136.34, 140.12, 142.68, 143.44, 152.59. Anal. Calcd
for C14H9ClN2: C, 69.86; H, 3.77; N, 11.64. Found: C, 69.74;
H, 3.69; N, 11.52.
2.2.14. 2-(3,4-Difluorophenyl)-6-Nitrobenzopyrazine (14,
Entry 14, Table 2)
Pink flaky crystal (91%); m.p. 211 °C; IR (KBr) 1525,
1
1465, 1428, 1344, 1188, 1125, 890, 821 cm-1; H NMR (600
MHz, d6-DMSO) δ 7.71-7.75 (m, 1H), 8.32-8.36 (m, 2H), 8.49
(t, J = 9.54, 1H), 8.58 (d, J = 9.06 Hz, 1H), 8.92 (s, 1H), 9.82 (s,
1H); 13C NMR (150 MHz, d6-DMSO) 115.51, 117.05, 117.18,
118.47, 118.58, 124.06, 124.89, 125.45, 131.10, 139.84, 143.82,
146.03, 147.39, 151.46; 19F NMR (564 MHz, CDCl3) -137.11